Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2021 | Updates from the Sarah Cannon Research Institute

Melissa Johnson • 8 Jan 2021
WCLC 2021
General Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, outlines her new position as Director of the Lung Cancer Program 2021. Dr Johnson also discusses the latest developments at the Sarah Cannon Research Institute, which has clinical practices throughout Tennessee, Florida and in Kansas City. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melissa Johnson

1:49
ADCs for lung cancer
Melissa Johnson • 27 Feb 2023
1:30
Cellular therapies for NSCLC
Melissa Johnson • 27 Feb 2023
3:46
Targeting IL-2 in advanced NSCLC
Melissa Johnson • 27 Feb 2023
2:42
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC
Melissa Johnson • 15 Sep 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals